IDEXX LABORATORIES, INC. (IDXX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 9, 2016, IDEXX Laboratories, Inc. (the “Company”) announced that Michael Williams, Ph.D., Executive Vice President, will be leaving the Company in February 2017 and is stepping down from his current position effective November 9, 2016. Dr. Williams will remain employed at the Company until February 28, 2017 in order to assist in the transition of his responsibilities. In connection with this, the Company agreed to pay Dr. Williams a lump sum of $460,000, the amount of $450,000 in 26 bi-weekly installments, and certain other benefits, all in consideration of Dr. Williams’s agreement to certain non-competition and non-solicitation obligations and a standard release of claims.

About IDEXX LABORATORIES, INC. (IDXX)